Navigation Links
Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California
Date:7/6/2015

Proove Biosciences, a commercial and research leader in Personalized Medicine, recently hosted their 2015 bi-annual Pain Management Medical Advisory Board meeting in Palm Springs, California. At the bi-annual meeting, the Medical Advisory Board met with Proove Biosciences’ executive Research and Development team to discuss new clinical practice and research ideas. The Board also discussed the development of new medical guidelines for Proove’s proprietary genetic tests and decided on the future direction and ever-evolving improvement of Proove Biosciences.    

“We have plans to expand our testing menu to offer 30 plus tests by the end of 2015”, Brian Meshkin, Founder and CEO of Proove Biosciences said. “Due to our consistent record growth, we have found that by gathering these influential and distinguished physicians and researchers and by fostering the discussion of Proove testing, we gain extremely constructive insights into the treatment of pain and the clinical value of our work.”

Proove testing is the future of medicine in general,” said Dr. Katrina Lewis of The Pain Center in Spokane, Washington. “I am a firm believer in their products, it has helped me make much better decisions for myself and my patients. These products will change patient lives for the better.”

Some others in attendance were Dr. Lynn Webster, immediate past-president of American Academy of Pain Medicine and vice president Scientific Affairs at PRA Health Sciences, Dr. Luda Diatchenko of McGill University, Dr. Standiford Helm, VP of the American Society of Interventional Pain Physicians, Dr. Gregory Smith of GS Medical and Comprehensive Pain Relief Group, and Dr. Steven Richeimer of University of Southern California Pain Center. Dr. Richheimer stated, “The biggest takeaway from this meeting was realizing the potential! This field is going to change the science of pain and the clinical practice of pain management - and Proove is well positioned to be the leader.”    

About Proove Biosciences Our Mission is to Change the Future of Medicine. Proove is the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could’ve ever prescribed medications without knowing how a patient would respond. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of personalized pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve outcomes – both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proove.com or call toll free 855-PROOVE-BIO (855-776-6832).

Read the full story at http://www.prweb.com/releases/2015/07/prweb12831553.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
2. Proove CEO and Vice Chairman of the Howard County Board of Education, Brian Meshkin, Selected as one of Howard County's Finest Under 39 by the Cystic Fibrosis Foundation
3. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
4. Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree
5. Proove Biosciences Will Be Exhibiting At The 2013 Common Sense Pain Management Conference
6. Proove Biosciences to Present Research on the Genetics of Pain Medicine and Exhibit at ASRA’s 12th Annual Pain Medicine Meeting
7. Proove Biosciences Will Be Exhibiting at the National Workers Compensation Conference and Expo on November 20-22
8. Proove Biosciences CEO Brian Meshkin Wins 2013 Bridging the Gap Award by the Greater Baltimore Committee
9. Proove Biosciences Successfully Presents Data and Exhibits at the Eastern Pain Association’s Annual Meeting in New York, New York
10. Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting
11. Proove Biosciences Exhibits Industry Leading Data and Research at PAINWeek 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2018)... , ... November 19, 2018 , ... ... to announce the release of the Chinese translation of Best Practices: Recommendations for ... is a practice-changing publication aimed at advancing the science of biobanking to meet ...
(Date:11/15/2018)... FRANCISCO (PRWEB) , ... November 14, 2018 , ... ... campaign, bringing the world’s first self-learning snore-reduction mask to the public. It is ... a poorer quality of sleep for themselves and their partner. The resulting daytime ...
(Date:11/13/2018)... ... November 13, 2018 , ... Aditya Humad, Managing ... last week that asserts it is still trending upward with growing valuations based ... analysis describes market consolidation, pricing pressure and increased competition as reasons often cited ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... Valenzuela, PhD, co-Founder, Chief Executive Officer and President of Andes Biotechnologies, to its ... the world, Dr. Valenzuela brings to uBiome expertise on the genetic studies of ...
Breaking Biology Technology:
(Date:12/5/2018)... ... December 04, 2018 , ... ... expertise and existing IP in the development of innovative solutions for which high-speed ... into diverse systems from microfluidics to industrial machinery and instrumentation, allowing partner companies ...
(Date:11/29/2018)... PRUSSIA, Pa. (PRWEB) , ... November 29, 2018 ... ... equity investment in Semba Biosciences with the intention of acquiring full ownership. The ... Equity Participation Agreement was executed on November 14, 2018. “We are extremely pleased ...
(Date:11/27/2018)... ... November 26, 2018 , ... uBiome, the leader in microbial ... IBDwatch and Gastroenterology Fellow at the University of Louisville, to its Medical Advisory ... Dr. Wuerth will bring to uBiome knowledge and research on IBD. The appointment ...
Breaking Biology News(10 mins):